A Real World Data Collection of Human Amniotic Membrane(s) on Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers and Post Operative Wounds.
Completed
Conditions studied: Venous Leg Ulcer (VLU), Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
In brief
This study is designed to evaluate the effectiveness of Tri-Membrane Wrap™, Membrane Wrap™ and Membrane Wrap-Hydro™ compared to the effectiveness of Standard of Care alone though a retrospective data collection.
Key facts
- Study ID
- NCT07078968
- Run by
- BioLab Holdings
- People needed
- 500
- Starts
- 2025-04-23
- Expected to finish
- 2025-10-01
- Last updated by the study team
- 2026-06-01
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject had the presence of diabetic foot ulcers, Venous insufficiency ulcers, pressure ulcers and/or post-operative wounds
- Subject has retrospectively been treated with Tri-Membrane Wrap™, Membrane Wrap™ and Membrane Wrap-Hydro™ or Subject has retrospectively been treated with Standard of Care only.
- Subjects should have been treated from January 2022 to present day.
You may not qualify if…
- Subjects that did not have a wound closure verification appointment.
- Any subject who received any product other than Tri-Membrane Wrap™, Membrane Wrap™ and Membrane Wrap-Hydro™ during their treatment time.
Where it is running
- Athena Specialty Group — Phoenix, Arizona, United States
- Revive Advanced Wound Care — Toms River, New Jersey, United States
- Houston Foot and Ankle Care — Houston, Texas, United States
- Houston Foot Dr — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.